Literature DB >> 25333052

Moyamoya syndrome associated with Graves' disease: a case series study.

Jun Ni1, Li-Xin Zhou1, Yan-Ping Wei1, Ming-Li Li1, Wei-Hai Xu1, Shan Gao1, Li-Ying Cui1.   

Abstract

OBJECTIVE: The aim of this study was to describe the clinical and radiological findings of patients with moyamoya syndrome and Graves' disease. Possible mechanisms predisposing these individuals to ischemic stroke are discussed.
METHODS: We retrospectively analyzed 12 consecutive patients with both moyamoya syndrome and Graves' disease. Moyamoya vasculopathy was diagnosed by digital subtract angiography or magnetic resonance angiography (MRA). The clinical characteristics, laboratory data, vascular radiological characteristics and outcome were reported.
RESULTS: All patients were female and mean age was 33.33±12.65 years. Stenosis or occlusion of bilateral terminal internal carotid artery and/or proximal anterior/middle cerebral arteries was found in nine patients. Among them, three patients displayed asymmetrical stenosis. In addition, there were three patients with probable unilateral moamoya syndrome. Eleven patients presented with ischemic stroke and/or transient ischemic attack (TIA) and one with dizziness. Thyroid function tests demonstrated elevated thyroid hormone levels and suppressed thyroid stimulating hormone levels in all the patients with ischemic events. All patients received anti-thyroid therapy and two had recurrent ischemic attack after drug withdrawal.
CONCLUSIONS: Moyamoya syndrome associated Graves' disease often presented with asymmetric stenosis or occlusion. We hypothesize cerebrovascular hemodynamic changes due to thyrotoxicosis contribute to the ischemic events.

Entities:  

Keywords:  Graves’ disease; Moyamoya syndrome; thyrotoxicosis; treatment

Year:  2014        PMID: 25333052      PMCID: PMC4200642          DOI: 10.3978/j.issn.2305-5839.2014.08.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  15 in total

Review 1.  Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.

Authors:  Shigeo Ohba; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2011-03-19       Impact factor: 3.042

2.  Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study.

Authors:  Hao Li; Zheng-Shan Zhang; Zhen-Nan Dong; Mai-Juan Ma; Wei-Zhong Yang; Cong Han; Ming-Mei Du; Yun-Xi Liu; Hong Yang; Wei Liu; Lian Duan; Wu-Chun Cao
Journal:  Stroke       Date:  2011-02-24       Impact factor: 7.914

3.  Progression of unilateral moyamoya disease: A clinical series.

Authors:  Michael E Kelly; Teresa E Bell-Stephens; Michael P Marks; Huy M Do; Gary K Steinberg
Journal:  Cerebrovasc Dis       Date:  2006-05-09       Impact factor: 2.762

4.  Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.

Authors:  Xiang-Yang Bao; Lian Duan; De-Sheng Li; Wei-Zhong Yang; Wei-Jian Sun; Zheng-Shan Zhang; Rui Zong; Cong Han
Journal:  Cerebrovasc Dis       Date:  2012-11-08       Impact factor: 2.762

5.  Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.

Authors:  Shinji Nagata; Toshio Matsushima; Takato Morioka; Koichiro Matsukado; Futoshi Mihara; Tomio Sasaki; Masashi Fukui
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

Review 6.  Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.

Authors:  Shaneela Malik; Andrew N Russman; Angelos M Katramados; Brian Silver; Panayiotis D Mitsias
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-12-04       Impact factor: 2.136

7.  A clinical comparison of definite moyamoya disease between South Korea and Japan.

Authors:  K Ikezaki; D H Han; T Kawano; N Kinukawa; M Fukui
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

Review 8.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

9.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.

Authors:  Edward R Smith; Craig D McClain; Matthew Heeney; R Michael Scott
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

View more
  4 in total

1.  Severe Cerebral Vasospasm in Patients with Hyperthyroidism.

Authors:  Hyuk-Jin Oh; Seok-Mann Yoon; Jae-Sang Oh; Jai-Joon Shim; Hack-Gun Bae
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-12-31

Review 2.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

3.  Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report.

Authors:  Shou-Chen Ren; Bao-Qin Gao; Wei-Li Yang; Wei-Xin Feng; Jian Xu; Shao-Wu Li; Yong-Jun Wang
Journal:  Exp Ther Med       Date:  2016-10-03       Impact factor: 2.447

4.  An extensive posterior circulation infarction secondary to primary hyperthyroidism accompanied with superior mesenteric artery syndrome: A case report and description of patho-physiological association.

Authors:  Hong-Kai Wang; Wen-Hsuan Huang; Ko-Ting Chen
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.